Aromatase inhibitors in premenopausal women: the need for proper contraceptive counseling.
Vandenput
Ingrid
I
Vergote
Ignace
I
Amant
Frederic
F
Neven
Patrick
P
Paridaens
Robert
R
Christiaens
Marie-Rose
MR
D000032:Abortion, Therapeutic; D000328:Adult; D018931:Antineoplastic Agents, Hormonal / Q000008:administration & dosage / Q000494:pharmacology*; D047072:Aromatase Inhibitors / Q000008:administration & dosage / Q000494:pharmacology*; D001943:Breast Neoplasms / Q000188:drug therapy / Q000473:pathology / Q000601:surgery; D018270:Carcinoma, Ductal, Breast / Q000188:drug therapy / Q000556:secondary / Q000601:surgery; D017024:Chemotherapy, Adjuvant; D003267:Contraception / Q000379:methods; D003376:Counseling; D005260:Female; D006301:Health Services Needs and Demand; D006801:Humans; D015411:Mastectomy, Modified Radical; D020380:Needs Assessment; D010051:Ovarian Neoplasms / Q000556:secondary; D010053:Ovary / Q000187:drug effects*; D011247:Pregnancy; D017697:Premenopause
D018931:Antineoplastic Agents, Hormonal; D047072:Aromatase Inhibitors